CLDN5 and multiple sclerosis: In experimental autoimmune encephalomyelitis, a well-characterized model of multiple sclerosis changes in claudin-5 immunostaining in brain vessels were evident at a very early disease stage, while the initially preserved occludin pattern showed alterations at more advanced stages (Errede et al., 2012).